Despite recent moves by the Biden administration and Congress to facilitate access to the opioid use disorder treatment buprenorphine, including through telehealth, patients are still facing barriers to getting their prescriptions filled at local pharmacies, according to a new study released in JAMA Open Network. Dispensing regulations imposed by federal and state governments may be contributing to lack of access at retail pharmacies, the study says. The Drug Enforcement Administration recently extended telehealth prescribing for the OUD treatment for the...